As Makary Steps Down, Pro-Lifers Await Movement From Trump FDA On Abortion Drugs
1 Trending: Any Vote For Democrats Is Now A Vote For Their Plan To Overthrow SCOTUS
2 Trending: Democrats Ask SCOTUS To Classify Virginia’s 45-Day Election As A ‘Single Day’ Event
3 Trending: Because She Ignored The Law, An Activist Judge Freed An Alleged Murderer
4 Trending: Election Integrity Group Challenges Illinois’ ‘Unconstitutional’ Racial Gerrymandering Law
As Makary Steps Down, Pro-Lifers Await Movement From Trump FDA On Abortion Drugs
Makary’s departure will prove to be a pivotal point for pro-lifers who want to see the administration take action on abortion pills.
Share Article on Facebook
Share Article on Twitter
Share Article on Truth Social
Share Article via Email
U.S. Food and Drug Administration Commissioner Marty Makary resigned on Tuesday after months of pressure from pro-life groups to not only review approval of the popular abortion drug linked to an 11 percent maternal injury rate, but also reinstate safeguards that were present during the first Trump administration.
The Wall Street Journal, New York Times, and CNN reported on Friday that President Donald Trump planned to “fire” Makary, rumors that the commander-in-chief claimed he had read but knew “nothing about.” By Tuesday, news broke that Makary stepped down.
🚨 REPORTER: What's going on with FDA Commissioner Marty Makary?PRESIDENT TRUMP: Nothing much.REPORTER: Are you gonna fire him?TRUMP: I've been reading about it, but I know nothing about it! pic.twitter.com/8rGLl5ixXH— Eric Daugherty (@EricLDaugh) May 8, 2026
🚨 REPORTER: What's going on with FDA Commissioner Marty Makary?PRESIDENT TRUMP: Nothing much.REPORTER: Are you gonna fire him?TRUMP: I've been reading about it, but I know nothing about it! pic.twitter.com/8rGLl5ixXH
The reason for Makary’s departure was not immediately clear, but the pro-life movement quickly hailed his exit as a win and an opportunity to replace him with a motivated ally.
“We look forward to a new FDA Commissioner who will put an end to the mail-order abortion drug regime,” SBA Pro-Life President Marjorie Dannenfelser wrote on X. “We must return immediately to the 1st Trump Administration standard of in-person dispensing to protect women from coercion and abuse and allow the enforcement of pro-life state laws.”
We look forward to a new FDA Commissioner who will put an end to the mail-order abortion drug regime. We must return immediately to the 1st Trump Administration standard of in-person dispensing to protect women from coercion and abuse and allow the enforcement of pro-life state…— Marjorie Dannenfelser (@marjoriesba) May 12, 2026
We look forward to a new FDA Commissioner who will put an end to the mail-order abortion drug regime. We must return immediately to the 1st Trump Administration standard of in-person dispensing to protect women from coercion and abuse and........
